Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 320.13M
March 31, 2026 302.96M
December 31, 2025 289.23M
September 30, 2025 276.85M
June 30, 2025 248.18M
March 31, 2025 258.61M
December 31, 2024 241.24M
September 30, 2024 234.05M
Date Value
June 30, 2024 228.49M
March 31, 2024 218.70M
December 31, 2023 185.38M
September 30, 2023 191.70M
June 30, 2023 183.45M
March 31, 2023
December 31, 2022 150.50M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Rhelion Life Sciences Corp. 18.81M
TelyRx Holdings, Inc. 15.47M
George Weston Ltd. 4.525B
Loblaw Cos. Ltd. 10.97B
Empire Co. Ltd. 5.115B

Shareholders Equity (Quarterly) Related Metrics